HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡ ±âÀÚȸ¿ø½Åû
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2024³â04¿ù20ÀÏsat
±â»çÃÖÁ¾ÆíÁýÀÏ: 2024-04-19 17:18:24
´º½ºÈ¨ > µ¿Á¤
2019³â03¿ù18ÀÏ 08½Ã53ºÐ
±ÛÀÚÅ©±â ±â»ç³»¿ë À̸ÞÀϺ¸³»±â ´º½ºÇÁ¸°Æ®Çϱ⠴º½º½ºÅ©·¦Çϱâ
°Ç±¹´ëº´¿ø ±èÁø±¹ ±³¼ö '´ëÇѺñ°úÇÐȸ ¿ì¼ö ³í¹®»ó' ¼ö»ó

[º¸°ÇŸÀÓÁî] °Ç±¹´ëº´¿ø À̺ñÀÎÈÄ-µÎ°æºÎ¿Ü°ú ±èÁø±¹ ±³¼ö(»çÁø)°¡ Á¦57Â÷ ´ëÇѺñ°úÇÐȸ Ãá°èÇмú´ëȸ¿¡¼­ ÀÓ»ó ºÎ¹® ¿ì¼ö³í¹®»óÀ» ¹Þ¾Ò´Ù.
½Ã»ó½ÄÀº Áö³­ 9ÀÏ~10ÀÏ ¼­¿ï µå·¡°ï½ÃƼ 3Ãþ ±×·£µåº¼·ë¿¡¼­ Ä¡·¯Á³´Ù.

³í¹®ÀÇ Á¦¸ñÀº 'ÈÄ°¢ ±â´É¿¡ ´ëÇÑ ¼±º°°Ë»ç·Î¼­ ÀÚ°¡ ÃøÁ¤ ÈÄ°¢ ¼³¹®ÁöÀÇ ÀÓ»ó ½ÇÇà °¡´É¼º(Clinical Feasibility of Scent Survey for Screening Test for Olfactory Function)'ÀÌ´Ù.

ÀÌ ³í¹®Àº ÈÄ°¢ ±â´É ¼±º° °Ë»çÁöÀÎ ÀÚ°¡ ÃøÁ¤ ÈÄ°¢ ¼³¹®Áö(Scent survey for screening, SSS)¿Í ´Ù¸¥ ÈÄ°¢ ±â´É °Ë»ç¿Í ºñ±³ ºÐ¼®ÇÑ ³í¹®À¸·Î ƯÈ÷ KVSSII °Ë»ç¿Í ºñ±³ÇØ È¿¿ë¼ºÀ» Áõ¸íÇØ ³Â´Ù.

±è ±³¼ö´Â "¿¬±¸ °á°ú SSS Å×½ºÆ®´Â °£´ÜÇÏ°Ô ÈÄ°¢ ±â´ÉÀ» °Ë»çÇÒ ¼ö ÀÖ¾î ÀÇ·á ¼­ºñ½º Á¢±ÙÀÌ ¾î·Á¿î Áö¿ª¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Ù"¸ç "Àη°ú ºñ¿ë, ½Ã°£ µîÀ» ´ÜÃàÇÒ ¼ö ÀÖ´Â ÀåÁ¡µµ ÀÖ¾î °Ë»ç·Î¼­ ÀÇ·á±â°ü¿¡¼­ À¯¿ëÇÏ°Ô »ç¿ëÇÒ ¼ö ÀÖ´Ù´Â °á·ÐÀ» ¾ò¾ú´Ù"°í ¹àÇû´Ù.

°ü·Ã±â»ç°¡ ¾ø½À´Ï´Ù
´º½º½ºÅ©·¦Çϱâ
Á¶ÇöÁø (bktimes@naver.com) ±âÀÚ 
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
µ¿Á¤¼½¼Ç ¸ñ·ÏÀ¸·Î
Ȳ°Ç ÀÎÇϴ뺴¿ø ±³¼ö, ´ë...
°í´ë ¾È¾Ïº´¿ø ¹Ú¼º¹Ì ±³¼ö...
¹é¿ë¼ö ÀÎÇϴ뺴¿ø ±³¼ö, ...
±èµ¿±Ô ±³¼ö, ¹Ì±¹¾Ë·¹¸£±â...
½ÅÀÓÈñ ±³¼ö, FDA ÃÊû ÀÇ...
´ÙÀ½±â»ç : ´ë°¡´ëº´¿ø À̵¿±¹ ±³¼ö '´ëÇÑÅëÁõ-ÀÚÀ²½Å°æÇÐȸ Á¦2´ë ȸÀå' ¼±Ãâ (2019-03-19 18:06:54)
ÀÌÀü±â»ç : ÀÌÈ­ÀÇ´ë ÀÌÁöÈñ ±³¼öÆÀ, ¡®´ë½Ä¼¼Æ÷ÀÇ ¾Ï ÀüÀÌ ¾ïÁ¦ È¿°ú¡¯ È®ÀÎ (2019-03-15 19:11:44)
º´¿ø°è, "°è...
º´¿ø°è, "°è¹¦³â...
Á¦¾à¡¤°Ç½Ä 12°³...
°Çº¸°ø´Ü, ¼Ò¼Ó±â°ü '¼­¿ï¿ä¾ç...
¼ºÀåÇÏ°íÇ ´ç½Å, "Áö±Ý ´ë¿õ,...
º¸·ÉÁ¦¾à, ¿Ã »ó¹Ý±â '¿µ¾÷Á÷ ...
°Çº¸°ø´Ü, ¿ÃÇØ '°³¹æÇü Á÷°ú ...
°Çº¸°ø´Ü, '¿Ã Á¦3Â÷ °³¹æÇü ...
³í¹®) Overcoming BRAF and CDK4/6 inhibitor ...  
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶